The lifeblood of good science is the communication of experimental results to scientific peers. The tried and true method of peer-review and publication in a reputable journal is fundamental to the advance of scientific insight and, ultimately, to the discovery of innovative drugs. As part of the wider global scientific community, NIBR encourages its scientists to publish the results of their research in a timely and rigorous manner, and to do so in highly regarded, openly accessible, and relevant scientific and medical journals. NIBR is committed to being a full partner with academia and industry in the open scientific dialogue necessary to transform fundamental genetic and chemical knowledge into the revolutionary drugs of tomorrow.

To learn more about the most recent and relevant publications by NIBR scientists, please visit the respective Disease Areas or Expertise Platforms sections and look for the Publications paragraph.

NIBR Science is the quarterly magazine highlighting scientific achievements at the Novartis Institutes for BioMedical Research (NIBR). Features, Nota Bene stories and perspectives, bring to life the drug discovery process at NIBR and the exciting science underlying it. Profiles accentuate the persons behind the scientific experiment and progress.

Winter 05 (PDF, 7.3 MB)	Spring 05 (PDF, 3.2 MB)	Summer 05 (PDF, 2.6 MB)	Winter 06 (PDF, 4.9 MB)

Winter 04 (PDF, 4.3 MB)	Spring 04 (PDF, 5.8 MB)	Summer 04  (PDF, 5.5 MB)	Fall 04 (PDF, 5.4 MB)

Please note that there will be no more NIBR Science issues. We are working on the concept of a different type of publication instead.

This brochure gives an overview of the Novartis Institutes for BioMedical Research. It explains our approach to research, our strategy in facing challenges, our commitment to collaborations, and our progress towards the future.

This brochure documents the transformation of the 250 Massachusetts Avenue building in Cambridge, MA, from a candy factory to the new NIBR global headquarters.